ResearcherBengbu Medical CollegeNo recent work listed

Qiong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0677-7737; OpenAlex author ID A5101490787. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper

Papers 2

Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells. Co-author DOI 10.2174/1568009614666140226114015 ↗
The Role of EMT in Pancreatic Cancer Progression. Co-author DOI 10.4172/2165-7092.1000e121 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lucio Miele · 1 shared paper, 2012 · strength 0.06
- Paper The Role of EMT in Pancreatic Cancer Progression. DOI 10.4172/2165-7092.1000e121 ↗
Rui Wang · 1 shared paper, 2014 · strength 0.05
- Paper Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cance… DOI 10.2174/1568009614666140226114015 ↗
Jun Xia · 1 shared paper, 2014 · strength 0.05
- Paper Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cance… DOI 10.2174/1568009614666140226114015 ↗
Zhiwei Peter Wang · 1 shared paper, 2014 · strength 0.05
- Paper Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cance… DOI 10.2174/1568009614666140226114015 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.